12/2/2025 4:16:31 PM Skinny labels ≠ safe harbor: evolving liability for second medical use patents in Germany By Andreas Obermeier Anna Wolters-Höhne Phoebe Greybanks Recent German court decisions have fundamentally shifted the risk landscape for generic and biosimilar companies facing second medical...
10/27/2025 11:54:53 AM Navigating the interplay of MDR and AIA: New MDCG Guidance on Medical Device AI Under the EU AI Act: EU and UK perspectives By Pieter Erasmus Maud van Haaren Hester Borgers The EU regulatory landscape for medical devices making use of artificial intelligence (MDAI) has become significantly more complex with...